510(k) K260333
K260333 is an FDA 510(k) premarket notification submitted by Diasorin Molecular, LLC for the device "LIAISON NES Group A Strep; LIAISON NES Group A Strep Control Swab Kit". The FDA issued a decision of Substantially Equivalent on June 15, 2026. The device falls under product code PGX (Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System), a Class II device regulated under 21 CFR 866.2680. Diasorin Molecular, LLC has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 15, 2026
- Date Received
- February 2, 2026
- Clearance Type
- Dual Track
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
- Device Class
- Class II
- Regulation Number
- 866.2680
- Review Panel
- MI
- Submission Type
An in vitro diagnostic test for the detection of Group A, C and G beta hemolytic Streptococcus in throat swab specimens from symptomatic patients.